A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

NCT05126758 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Dystrophies
Muscular Dystrophy, Duchenne
Muscular Disorders, Atrophic
Muscular Diseases
Neuromuscular Diseases
Genetic Diseases, X-Linked
Genetic Diseases, Inborn
Nervous System Diseases

Interventions

BIOLOGICAL: Deramiocel (CAP-1002)
BIOLOGICAL: Placebo

Sponsor

Capricor Inc.